VTVT: vTv Therapeutics Inc. Stock

by  •  • Comments Off on VTVT: vTv Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 49.16
Enterprise Value ($M) 14.52
Book Value ($M) 14.30
Book Value / Share 5.47
Price / Book 3.44
NCAV ($M) 14.15
NCAV / Share 5.42
Price / NCAV 3.47

Profitability (mra)
Return on Invested Capital (ROIC) -1.27
Return on Assets (ROA) -0.34
Return on Equity (ROE) -0.71

Liquidity (mrq)
Quick Ratio 7.34
Current Ratio 7.34

Balance Sheet (mrq) ($M)
Current Assets 38.11
Assets 38.27
Liabilities 23.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.02
Operating Income -24.18
Net Income -18.46
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -25.31
Cash from Investing 0.00
Cash from Financing 52.61

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G Fmr Llc 7.32
2024-03-22 13D/A MacAndrews & Forbes Inc. 50.30 -97.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 3,426 15,099 22.69
2025-04-16 1,667 6,766 24.64
2025-04-15 1,763 6,341 27.80
2025-04-14 802 4,301 18.65

(click for more detail)

Similar Companies
VKTX – Viking Therapeutics, Inc. VSTM – Verastem, Inc.
VTGN – Vistagen Therapeutics, Inc. VXRT – Vaxart, Inc.
VYNE – VYNE Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io